Cefepime-Associated Neurotoxicity in a Pediatric Patient With Stage V Chronic Kidney Disease
- 8 September 2022
- journal article
- research article
- Published by SAGE Publications in Journal of Pharmacy Practice
- Vol. 37 (1) , 243-247
Abstract
Background: Studies in adult patients suggest cefepime can cause neurotoxicity, including disorientation, seizures, and coma, particularly when present at high concentrations. Patients with underlying kidney dysfunction or central nervous system anomalies are at particularly high risk. There is a relative paucity of pediatric literature on the neurotoxic effects of cefepime. Case Report: Herein is reported the case of a 2-year-old patient with chronic kidney disease receiving cefepime for Serratia marcescens bacteremia who experienced agitation, tremor, and inconsolability in the setting of an elevated cefepime trough that improved with cefepime discontinuation alone. Conclusions: Pediatric patients with acute and chronic kidney disease are at risk of cefepime-related neurologic changes. Therapeutic drug monitoring for cefepime in patients with kidney dysfunction or baseline neurologic abnormalities may help inform appropriate antimicrobial dosing and avoidance of toxicity.Keywords
This publication has 19 references indexed in Scilit:
- Pediatric Cefepime NeurotoxicityPediatric Neurology, 2012
- Blood and CSF monitoring of cefepime-induced neurotoxicity: nine case reportsJournal of Antimicrobial Chemotherapy, 2012
- Cefepime Neurotoxicity in an Adolescent Cystic Fibrosis Patient with Aminoglycoside-Induced Acute Kidney InjuryJournal of Pharmacy Technology, 2011
- Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shockCritical Care, 2010
- Efficacy and Safety of Cefepime in Pediatric Patients: A Systematic Review and Meta-AnalysisThe Journal of Pediatrics, 2010
- Cefepime: a reappraisal in an era of increasing antimicrobial resistanceExpert Review of Anti-infective Therapy, 2008
- Cephalosporin-Induced Neurotoxicity: Clinical Manifestations, Potential Pathogenic Mechanisms, and the Role of Electroencephalographic MonitoringAnnals of Pharmacotherapy, 2008
- Cefepime-induced non-convulsive status epilepticus in a peritoneal dialysis patientPediatric Nephrology, 2004
- Evidence for the involvement of GABAA receptor blockade in convulsions induced by cephalosporinsNeuropharmacology, 2003
- Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and childrenAntimicrobial Agents and Chemotherapy, 1995